Cancer among patients with diabetes, obesity and abnormal blood lipids: a population-based register study in Sweden (original) (raw)

• LeRoith D, Novosyadlyy R, Gallagher EJ, Lann D, Vijayakumar A, Yakar S (2008) Obesity and type 2 diabetes are associated with an increased risk of developing cancer and a worse prognosis; epidemiological and mechanistic evidence. Exp Clin Endocrinol Diabetes 116(Suppl 1):S4–S6
  Article PubMed CAS Google Scholar
• Mori M, Saitoh S, Takagi S, Obara F, Ohnishi H, Akasaka H et al (2000) A Review of Cohort Studies on the Association Between History of Diabetes Mellitus and Occurrence of Cancer. Asian Pac J Cancer Prev 1(4):269–276
  PubMed Google Scholar
• Hjartaker A, Langseth H, Weiderpass E (2008) Obesity and diabetes epidemics: cancer repercussions. Adv Exp Med Biol 630:72–93
  Article PubMed Google Scholar
• Giovannucci E, Harlan DM, Archer MC, Bergenstal RM, Gapstur SM, Habel LA et al (2010) Diabetes and cancer: a consensus report. Diabetes Care 33(7):1674–1685 [Epub 2010/07/01]
  Article PubMed Google Scholar
• Vigneri P, Frasca F, Sciacca L, Pandini G, Vigneri R (2009) Diabetes and cancer. Endocr Relat Cancer 16(4):1103–1123 [Epub 2009/07/22]
  Article PubMed CAS Google Scholar
• Seshasai SR, Kaptoge S, Thompson A, Di Angelantonio E, Gao P, Sarwar N et al (2011) Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med 364(9):829–841 [Epub 2011/03/04]
  Article PubMed CAS Google Scholar
• Kritchevsky S (1992) Serum cholesterol and cancer risk: an epidemiologic perspective. Annu Rev Nutr 12:391–416
  Article PubMed CAS Google Scholar
• Michalaki V, Koutroulis G, Syrigos K, Piperi C, Kalofoutis A (2005) Evaluation of serum lipids and high-density lipoprotein subfractions (HDL2, HDL3) in postmenopausal patients with breast cancer. Mol Cell Biochem 268(1–2):19–24
  Article PubMed CAS Google Scholar
• Ahn J, Lim U, Weinstein SJ, Schatzkin A, Hayes RB, Virtamo J et al (2009) Prediagnostic total and high-density lipoprotein cholesterol and risk of cancer. Cancer Epidemiol Biomarkers Prev 18(11):2814–2821 [Epub 2009/11/06]
  Article PubMed CAS Google Scholar
• Jacobs EJ, Gapstur SM (2009) Cholesterol and cancer: answers and new questions. Cancer Epidemiol Biomarkers Prev 18(11):2805–2806 [Epub 2009/11/06]
  Article PubMed Google Scholar
• Drummond MF, Botten G, Hakkinen U, Pedersen KM (2006) Assessing the quality of Swedish health economics research. Scand J Public Health 34(6):566–570 [Epub 2006/11/3]
  Article PubMed Google Scholar
• Barlow L, Westergren K, Holmberg L, Talback M (2009) The completeness of the Swedish Cancer Register: a sample survey for year 1998. Acta Oncol 48(1):27–33 [Epub 2008/09/04]
  Article PubMed Google Scholar
• The National Board of Health and Welfare (2008) Cancer incidence in Sweden 2007. Health Dis 11:1–117
  Google Scholar
• Huxley R, Ansary-Moghaddam A, de Gonzalez AB, Barzi F, Woodward M (2005) Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer 92(11):2076–2083 [Epub 2005/05/12]
  Article PubMed CAS Google Scholar
• Li D, Tang H, Hassan MM, Holly EA, Bracci PM, Silverman DT (2010) Diabetes and risk of pancreatic cancer: a pooled analysis of three large case-control studies. Cancer Causes Control [Epub 2010/11/26]
• Genkinger JM, Spiegelman D, Anderson KE, Bernstein L, van den Brandt PA, Calle EE et al (2010) A pooled analysis of 14 cohort studies of anthropometric factors and pancreatic cancer risk. Int J Cancer 129(7):1708–1717 [Epub 2010/11/26]
  Article Google Scholar
• Colhoun HM (2009) Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group. Diabetologia 52(9):1755–1765 [Epub 2009/07/16]
  Article PubMed CAS Google Scholar
• Hemkens LG, Grouven U, Bender R, Gunster C, Gutschmidt S, Selke GW et al (2009) Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study. Diabetologia 52(9):1732–1744 [Epub 2009/07/01]
  Article PubMed CAS Google Scholar
• Jonasson JM, Ljung R, Talback M, Haglund B, Gudbjornsdottir S, Steineck G (2009) Insulin glargine use and short-term incidence of malignancies—a population-based follow-up study in Sweden. Diabetologia 52(9):1745–1754 [Epub 2009/07/10]
  Article PubMed CAS Google Scholar
• Mannucci E, Monami M, Balzi D, Cresci B, Pala L, Melani C et al (2010) Doses of insulin and its analogues and cancer occurrence in insulin-treated type 2 diabetic patients. Diabetes Care 33(9):1997–2003 [Epub 2010/06/17]
  Article PubMed CAS Google Scholar
• Becker S, Dossus L, Kaaks R (2009) Obesity related hyperinsulinaemia and hyperglycaemia and cancer development. Arch Physiol Biochem 115(2):86–96
  Article PubMed CAS Google Scholar
• Schiel R, Beltschikow W, Steiner T, Stein G (2006) Diabetes, insulin, and risk of cancer. Methods Find Exp Clin Pharmacol 28(3):169–175
  Article PubMed CAS Google Scholar
• Evans JM, Donnelly LA, Emslie-Smith AM, Alessi DR, Morris AD (2005) Metformin and reduced risk of cancer in diabetic patients. BMJ 330(7503):1304–1305
  Article PubMed Google Scholar
• Smith U, Gale EA (2009) Does diabetes therapy influence the risk of cancer? Diabetologia 52(9):1699–1708 [Epub 2009/07/15]
  Article PubMed CAS Google Scholar
• Siekmeier R, Scheuch G (2008) Inhaled insulin—does it become reality? J Physiol Pharmacol 59(Suppl 6):81–113
  PubMed Google Scholar
• Bonovas S, Filioussi K, Tsantes A (2004) Diabetes mellitus and risk of prostate cancer: a meta-analysis. Diabetologia 47(6):1071–1078
  Article PubMed CAS Google Scholar
• Kasper JS, Giovannucci E (2006) A meta-analysis of diabetes mellitus and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 15(11):2056–2062 [Epub 2006/11/23]
  Article PubMed Google Scholar
• Waters KM, Henderson BE, Stram DO, Wan P, Kolonel LN, Haiman CA (2009) Association of diabetes with prostate cancer risk in the multiethnic cohort. Am J Epidemiol 169(8):937–945
  Article PubMed Google Scholar
• Kasper JS, Liu Y, Giovannucci E (2009) Diabetes mellitus and risk of prostate cancer in the health professionals follow-up study. Int J Cancer 124(6):1398–1403
  Article PubMed CAS Google Scholar
• Frayling TM, Colhoun H, Florez JC (2008) A genetic link between type 2 diabetes and prostate cancer. Diabetologia 51(10):1757–1760
  Article PubMed CAS Google Scholar
• Chu DI, Freedland SJ (2010) Metabolic risk factors in prostate cancer. Cancer [Epub 2010/12/01]
• Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371(9612):569–578
  Article PubMed Google Scholar
• Giovannucci E, Michaud D (2007) The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas. Gastroenterology 132(6):2208–2225 [Epub 2007/05/15]
  Article PubMed CAS Google Scholar
• Ning Y, Wang L, Giovannucci EL (2009) A quantitative analysis of body mass index and colorectal cancer: findings from 56 observational studies. Obes Rev 11(1):19–30 [Epub 2009/06/23]
  Article PubMed Google Scholar
• Tornberg SA, Holm LE, Carstensen JM (1988) Breast cancer risk in relation to serum cholesterol, serum beta-lipoprotein, height, weight, and blood pressure. Acta Oncol 27(1):31–37 [Epub 1988/01/01]
  Article PubMed CAS Google Scholar
• Vatten LJ, Foss OP (1990) Total serum cholesterol and triglycerides and risk of breast cancer: a prospective study of 24,329 Norwegian women. Cancer Res 50(8):2341–2346 [Epub 1990/04/15]
  PubMed CAS Google Scholar
• Helzlsouer KJ, Alberg AJ, Norkus EP, Morris JS, Hoffman SC, Comstock GW (1996) Prospective study of serum micronutrients and ovarian cancer. J Natl Cancer Inst 88(1):32–37 [Epub 1996/01/03]
  Article PubMed CAS Google Scholar
• Bjørge T, Lukanova A, Tretli S, Manjer J, Ulmer H, Stocks T et al (2011) Metabolic risk factors and ovarian cancer in the Metabolic Syndrome and Cancer project. Int J Epidemiol 40(6):1667–1677 [Epub 2011/10/11]
  Article PubMed Google Scholar